top of page
Search
Recent Posts
See AllRESIST-TB is excited to share that Dr. Max O'Donnell is joining our steering committee! Max is an Associate Professor of Medicine and Epidemiology at Columbia University Irving Medical Center, where h
Researchers from the University of Virginia have recently received a grant from the Pittsfield Anti-Tuberculosis Association to create a global, web-based resource to further support nurses that are c
A six-month oral treatment for MDR-TB, and also specifically rifampicin-resistant, was found to be both more effective and more cost effective when compared to the longer therapies/medications current
bottom of page
Comments